TLR9 and prostate carcinoma: Prostate cancer is notorious for its plasticity allowing it to develop mechanisms for its self preservation, so it is possible that the proangiogenic properties of neutrophils in cancer [68] may be a tumor-intrinsic compensatory mechanism in response to the tumor-suppressive effects of other TLR9-activated immune cells.